SPONSOR
Du Juan
Total Trials
2
Recruiting
2
Phases
Phase 2
Du Juan is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Advance Pancreatic Cancer, Locally Advanced Pancreatic Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Du Juan
How many clinical trials has Du Juan sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Du Juan, of which 2 are actively recruiting participants. These trials cover conditions including Advance Pancreatic Cancer, Locally Advanced Pancreatic Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Du Juan research focus on?
Du Juan clinical trials span Advance Pancreatic Cancer, Locally Advanced Pancreatic Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Du Juan clinical trial?
To participate in a Du Juan trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Du Juan trials with current recruitment status updated daily.
Clinical Trials by Du Juan
NCT07110064 Phase 2
Recruiting
QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer
Advance Pancreatic Cancer
NCT06494514
Recruiting
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology